Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNotes PayablesOperating LeasesOther Accumulated ExpensesPayablesPreferred SharesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)Raw MaterialsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

HeartSciences (HSCS) Non-Current Assets (2022 - 2026)

HeartSciences filings provide 5 years of Non-Current Assets readings, the most recent being $2.5 million for Q1 2026.

  • On a quarterly basis, Non-Current Assets rose 18.35% to $2.5 million in Q1 2026 year-over-year; TTM through Jan 2026 was $8.7 million, a 3.57% increase, with the full-year FY2025 number at $2.1 million, down 4.55% from a year prior.
  • Non-Current Assets hit $2.5 million in Q1 2026 for HeartSciences, up from $2.2 million in the prior quarter.
  • In the past five years, Non-Current Assets ranged from a high of $2.5 million in Q1 2026 to a low of $130793.0 in Q3 2022.
  • Median Non-Current Assets over the past 5 years was $2.0 million (2025), compared with a mean of $1.4 million.
  • The widest YoY moves for Non-Current Assets: up 334.83% in 2023, down 13.6% in 2023.
  • HeartSciences' Non-Current Assets stood at $643706.0 in 2022, then decreased by 13.6% to $556147.0 in 2023, then soared by 275.47% to $2.1 million in 2024, then grew by 5.48% to $2.2 million in 2025, then grew by 11.49% to $2.5 million in 2026.
  • The last three reported values for Non-Current Assets were $2.5 million (Q1 2026), $2.2 million (Q4 2025), and $2.0 million (Q3 2025) per Business Quant data.